Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

12.97 -4.50 (-25.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Simulations Plus to Present at Baird 2022 Global Healthcare Conference
From Simulations Plus
Via Business Wire
Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa)
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Presented New Scientific Developments at PAGE 2022
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
From Simulations Plus
Via Business Wire
Simulations Plus Realizes Early Success with its Concierge Program
From Simulations Plus, Inc
Via Business Wire
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
From Simulations Plus, Inc.
Via Business Wire
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Successfully Delivers FDA-Funded Project
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at the Berenberg Discover AI Seminar
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Enters New Collaboration with Leading Animal Health Company
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
From Simulations Plus, Inc.
Via Business Wire
Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit, Dispensary of Hope
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.